123 related articles for article (PubMed ID: 7533115)
21. A hepatitis C virus core polypeptide expressed in chloroplasts detects anti-core antibodies in infected human sera.
Madesis P; Osathanunkul M; Georgopoulou U; Gisby MF; Mudd EA; Nianiou I; Tsitoura P; Mavromara P; Tsaftaris A; Day A
J Biotechnol; 2010 Feb; 145(4):377-86. PubMed ID: 19969031
[TBL] [Abstract][Full Text] [Related]
22. High level expression and purification of the Epstein-Barr virus encoded cytokine viral interleukin 10: efficient removal of endotoxin.
Salek-Ardakani S; Stuart AD; Arrand JE; Lyons S; Arrand JR; Mackett M
Cytokine; 2002 Jan; 17(1):1-13. PubMed ID: 11886166
[TBL] [Abstract][Full Text] [Related]
23. Evaluation of several affinity chromatographic supports for the purification of maltose-binding protein from Escherichia coli.
Kroviarski Y; Cochet S; Martineau P; Cartron JP; Bertrand O
J Chromatogr; 1993 Feb; 633(1-2):273-80. PubMed ID: 8450027
[TBL] [Abstract][Full Text] [Related]
24. High yield of active STb enterotoxin from a fusion protein (MBP-STb) expressed in Escherichia coli.
Handl CE; Harel J; Flock JI; Dubreuil JD
Protein Expr Purif; 1993 Aug; 4(4):275-81. PubMed ID: 8374296
[TBL] [Abstract][Full Text] [Related]
25. Expression of the measles virus nucleoprotein gene in Escherichia coli and assembly of nucleocapsid-like structures.
Warnes A; Fooks AR; Dowsett AB; Wilkinson GW; Stephenson JR
Gene; 1995 Jul; 160(2):173-8. PubMed ID: 7642091
[TBL] [Abstract][Full Text] [Related]
26. Maltose binding protein (MBP) fusion proteins with low or no affinity to amylose resins can be single-step purified using a novel anti-MBP monoclonal antibody.
Park JH; Choi EA; Cho EW; Hahm KS; Kim KL
Mol Cells; 1998 Dec; 8(6):709-16. PubMed ID: 9895124
[TBL] [Abstract][Full Text] [Related]
27. Expression of active streptolysin O in Escherichia coli as a maltose-binding-protein--streptolysin-O fusion protein. The N-terminal 70 amino acids are not required for hemolytic activity.
Weller U; Müller L; Messner M; Palmer M; Valeva A; Tranum-Jensen J; Agrawal P; Biermann C; Döbereiner A; Kehoe MA; Bhakdi S
Eur J Biochem; 1996 Feb; 236(1):34-9. PubMed ID: 8617283
[TBL] [Abstract][Full Text] [Related]
28. Expression of an active recombinant lysine 49 phospholipase A(2) myotoxin as a fusion protein in bacteria.
Giuliani CD; Iemma MR; Bondioli AC; Souza DH; Ferreira LL; Amaral AC; Salvini TF; Selistre-de-Araujo HS
Toxicon; 2001 Oct; 39(10):1595-600. PubMed ID: 11478968
[TBL] [Abstract][Full Text] [Related]
29. Expression of HCV genotype-4 core antigen in prokaryotic E. coli system for diagnosis of HCV infection in Egypt.
Saleh EM; Gouda AE; Medhat AM; Ahmed HO; Shemis MA
Protein Expr Purif; 2021 Dec; 188():105965. PubMed ID: 34461217
[TBL] [Abstract][Full Text] [Related]
30. Production of the chimeric-binding protein, maltose-binding protein-protein A, by gene fusion.
Kobatake E; Ikariyama Y; Aizawa M
J Biotechnol; 1995 Jan; 38(3):263-8. PubMed ID: 7765875
[TBL] [Abstract][Full Text] [Related]
31. Characterization of purified recombinant Bet v 1 with authentic N-terminus, cloned in fusion with maltose-binding protein.
Spangfort MD; Ipsen H; Sparholt SH; Aasmul-Olsen S; Larsen MR; Mørtz E; Roepstorff P; Larsen JN
Protein Expr Purif; 1996 Nov; 8(3):365-73. PubMed ID: 8936599
[TBL] [Abstract][Full Text] [Related]
32. Expression in E. coli and purification of a chimeric p22-NS3 recombinant antigen of hepatitis C virus (HCV).
Osborne S; Cecconato E; Griva S; Garetto F; Calogero R; Rosa C; Bonelli F
FEBS Lett; 1993 Jun; 324(3):253-7. PubMed ID: 8405360
[TBL] [Abstract][Full Text] [Related]
33. Expression of a recombinant Toxoplasma gondii ROP2 fragment as a fusion protein in bacteria circumvents insolubility and proteolytic degradation.
Jacquet A; Daminet V; Haumont M; Garcia L; Chaudoir S; Bollen A; Biemans R
Protein Expr Purif; 1999 Dec; 17(3):392-400. PubMed ID: 10600457
[TBL] [Abstract][Full Text] [Related]
34. Single-step purification and characterization of MBP (maltose binding protein)-DnaJ fusion protein and its utilization for structure-function analysis.
Ishii Y; Sonezaki S; Iwasaki Y; Tauchi E; Shingu Y; Okita K; Ogawa HI; Kato Y; Kondo A
J Biochem; 1998 Oct; 124(4):842-7. PubMed ID: 9756632
[TBL] [Abstract][Full Text] [Related]
35. Single amino acid substitutions on the surface of Escherichia coli maltose-binding protein can have a profound impact on the solubility of fusion proteins.
Fox JD; Kapust RB; Waugh DS
Protein Sci; 2001 Mar; 10(3):622-30. PubMed ID: 11344330
[TBL] [Abstract][Full Text] [Related]
36. Molecular basis for antibody cross-reactivity between the hepatitis C virus core protein and the host-derived GOR protein.
Zhang ZX; Chen M; Wallhagen K; Trojnar J; Magnius LO; Wahren B; Sällberg M
Clin Exp Immunol; 1994 Jun; 96(3):403-9. PubMed ID: 7516270
[TBL] [Abstract][Full Text] [Related]
37. Antibodies in human sera specific to hypervariable region 1 of hepatitis C virus can block viral attachment.
Zibert A; Schreier E; Roggendorf M
Virology; 1995 Apr; 208(2):653-61. PubMed ID: 7538251
[TBL] [Abstract][Full Text] [Related]
38. Construction of a tagging system for subcellular localization of proteins encoded by open reading frames.
Chuang CH; Hsu SC; Hsu CL; Hsu TC; Syu WJ
J Biomed Sci; 2001; 8(2):170-5. PubMed ID: 11287747
[TBL] [Abstract][Full Text] [Related]
39. Improved expression characteristics of single-chain Fv fragments when fused downstream of the Escherichia coli maltose-binding protein or upstream of a single immunoglobulin-constant domain.
Hayhurst A
Protein Expr Purif; 2000 Feb; 18(1):1-10. PubMed ID: 10648163
[TBL] [Abstract][Full Text] [Related]
40. Fusion expression of Helicobacter pylori neutrophil-activating protein in E.coli.
Kang QZ; Duan GC; Fan QT; Xi YL
World J Gastroenterol; 2005 Jan; 11(3):454-6. PubMed ID: 15637768
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
